The avian influenza virus subtype H16N3 is currently detectable in many countries. To examine the potential threat to humans of H16N3, researchers recently performed an extensive avian influenza surveillance in major wild bird gatherings across China from 2017-2019. The findings are published in Transboundary and Emerging Diseases.
The avian influenza virus subtype H16N3 is currently detectable in many countries. To examine the potential threat to humans of H16N3, researchers recently performed an extensive avian influenza surveillance in major wild bird gatherings across China from 2017-2019. The findings are published in Transboundary and Emerging Diseases.
The investigators isolated two H16N3 subtype influenza viruses that can bind to both human and avian-type cell receptors. They also found evidence that genetic material from other species has been introduced into the H16N3 avian influenza virus, which suggests that it may infect other species and could therefore pose a threat to animal and human health in the future.
“Consequently, it is necessary to increase monitoring of the emergence and spread of avian influenza subtype H16N3 in wild birds,” the authors wrote.
Additional Information
Link to Study: https://onlinelibrary.wiley.com/doi/10.1111/tbed.13511
About Journal
Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases.
About Wiley
Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.
Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com